1. Home
  2. NVAX vs OBK Comparison

NVAX vs OBK Comparison

Compare NVAX & OBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVAX
  • OBK
  • Stock Information
  • Founded
  • NVAX 1987
  • OBK 1912
  • Country
  • NVAX United States
  • OBK United States
  • Employees
  • NVAX N/A
  • OBK N/A
  • Industry
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • OBK Major Banks
  • Sector
  • NVAX Health Care
  • OBK Finance
  • Exchange
  • NVAX Nasdaq
  • OBK Nasdaq
  • Market Cap
  • NVAX 1.3B
  • OBK 1.2B
  • IPO Year
  • NVAX 1995
  • OBK 2018
  • Fundamental
  • Price
  • NVAX $8.60
  • OBK $35.12
  • Analyst Decision
  • NVAX Buy
  • OBK Buy
  • Analyst Count
  • NVAX 7
  • OBK 7
  • Target Price
  • NVAX $14.29
  • OBK $43.00
  • AVG Volume (30 Days)
  • NVAX 6.9M
  • OBK 152.1K
  • Earning Date
  • NVAX 11-11-2025
  • OBK 10-22-2025
  • Dividend Yield
  • NVAX N/A
  • OBK 1.69%
  • EPS Growth
  • NVAX N/A
  • OBK N/A
  • EPS
  • NVAX 2.54
  • OBK 2.23
  • Revenue
  • NVAX $1,078,718,000.00
  • OBK $340,866,000.00
  • Revenue This Year
  • NVAX $61.69
  • OBK $12.81
  • Revenue Next Year
  • NVAX N/A
  • OBK $7.25
  • P/E Ratio
  • NVAX $3.18
  • OBK $15.87
  • Revenue Growth
  • NVAX 9.22
  • OBK N/A
  • 52 Week Low
  • NVAX $5.01
  • OBK $28.80
  • 52 Week High
  • NVAX $15.22
  • OBK $41.17
  • Technical
  • Relative Strength Index (RSI)
  • NVAX 53.41
  • OBK 50.19
  • Support Level
  • NVAX N/A
  • OBK N/A
  • Resistance Level
  • NVAX $8.31
  • OBK $39.06
  • Average True Range (ATR)
  • NVAX 0.35
  • OBK 0.78
  • MACD
  • NVAX -0.25
  • OBK -1.76
  • Stochastic Oscillator
  • NVAX 99.19
  • OBK 88.90

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

About OBK Origin Bancorp Inc.

Origin Bancorp Inc is a financial holding company. The bank provides a broad range of financial services to businesses, municipalities, high-net-worth individuals, and retail clients. The bank principally operates in one business segment, community banking. The bank is engaged in attracting deposits from individuals and businesses and using these deposits and borrowed funds to originate commercial, residential mortgage, construction, and consumer loans. The bank generates the majority of its revenue from interest earned on loans and investments, service charges, and fees on deposit accounts.

Share on Social Networks: